Related references
Note: Only part of the references are listed.Dietary lycopene intake and risk of prostate cancer defined by ERG protein expression
Rebecca E. Graff et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2016)
TM4SF1: a new vascular therapeutic target in cancer
Chi-Iou Lin et al.
ANGIOGENESIS (2014)
Dietary Lycopene, Angiogenesis, and Prostate Cancer: A Prospective Study in the Prostate-Specific Antigen Era
Ke Zu et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Clinically Relevant Doses of Candesartan Inhibit Growth of Prostate Tumor Xenografts In Vivo through Modulation of Tumor Angiogenesis
Ahmed Alhusban et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
Angiogenesis in prostate cancer: onset, progression and imaging
Giovanna Russo et al.
BJU INTERNATIONAL (2012)
The TMPRSS2:ERG Rearrangement, ERG Expression, and Prostate Cancer Outcomes: A Cohort Study and Meta-analysis
Andreas Pettersson et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2012)
Do low-grade and low-volume prostate cancers bear the hallmarks of malignancy?
Hashim Uddin Ahmed et al.
LANCET ONCOLOGY (2012)
Commentary: Serum lycopene and prostate cancer progression: a re-consideration of findings from the prostate cancer prevention trial
Edward Giovannucci
CANCER CAUSES & CONTROL (2011)
Prospective Study of Prostate Tumor Angiogenesis and Cancer-Specific Mortality in the Health Professionals Follow-Up Study
Lorelei A. Mucci et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Gleason Score and Lethal Prostate Cancer: Does 3+4=4+3?
Jennifer R. Stark et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
How well does the gleason score predict prostate cancer death?: A 20-year followup of a population based cohort in Sweden
O Andrén et al.
JOURNAL OF UROLOGY (2006)
Correlation of vascular endothelial growth factor expression with fibroblast growth factor-8 expression and clinico-pathologic parameters in human prostate cancer
AF West et al.
BRITISH JOURNAL OF CANCER (2001)
Share Paper
